Replies to post #106010 on Innovation Pharmaceuticals Inc (IPIX)

[frrol]

I think I'm between the two camps: I think the efficacy references in the poster refer explicitly to the pre-clinical results and the fact that Shapiro allowed them to be cited in the poster is an implicit indication that he believes he's seeing efficacy.

Unless there's wording in the poster I'm missing. Can anyone show me using text highlights where I would be wrong?

[biodoc]

Thank you Karin. Also, there is a wealth of data and discussion of multiple mechanisms of action in the pre-clinical poster from 2011/12. Discussion of kevetrin's multiple mechanisms of action and the therapeutic implications of these multiple mechanisms are, imo, well worth revisiting.

2015 ASCO poster is a huge, huge validation. Now I find it much easier (and more believable) to further project the clinical work from the pre-clinical data.

[Snowy_Owl]

I've lost count of the times I've heard naysayers use the "just because it works in animals doesn't mean it will work in humans" argument.

KarinCA, thank you for pointing out that the ASCO poster has pretty much put that argument to rest.